-
公开(公告)号：US11524943B1
公开(公告)日：2022-12-13
申请号：US16769997
申请日：2018-12-05
Applicant: Vivace Therapeutics, Inc.
Inventor： Andrei W. Konradi , Tracy Tzu-Ling Tang Lin
IPC: C07D257/04 , C07D233/64 , C07D213/24 , C07D213/26 , C07D213/28 , C07D271/10 , C07D277/24 , C07D239/26 , C07D241/12 , C07D237/08 , C07D269/02 , C07D285/12 , C07D283/02 , A61K31/196 , A61K31/235 , A61K31/165 , A61P35/00 , C07D233/61 , C07D213/55 , C07D277/30 , C07D271/06 , C07D263/32 , C07D213/73
Abstract: Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
-
公开(公告)号：US12103902B2
公开(公告)日：2024-10-01
申请号：US17752649
申请日：2022-05-24
Applicant: Vivace Therapeutics, Inc.
Inventor： Andrei W. Konradi , Tracy Tzu-Ling Tang Lin
IPC: C07C235/66 , C07C255/24 , C07C311/51 , C07D213/40 , C07D213/61 , C07D213/73 , C07D217/24 , C07D217/26 , C07D233/64 , C07D241/12 , C07D257/04 , C07D305/06 , C07D305/08 , C07D333/70 , C07D401/12
CPC classification number: C07C235/66 , C07C255/24 , C07C311/51 , C07D213/40 , C07D213/61 , C07D213/73 , C07D217/24 , C07D217/26 , C07D233/64 , C07D241/12 , C07D257/04 , C07D305/06 , C07D305/08 , C07D333/70 , C07D401/12 , C07C2601/02 , C07C2601/04
Abstract: Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating diseases, such as cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
-
公开(公告)号：US11866431B2
公开(公告)日：2024-01-09
申请号：US17291765
申请日：2019-11-07
Applicant: Vivace Therapeutics, Inc.
Inventor： Andrei W. Konradi , Tracy Tzu-Ling Tang Lin
IPC: C07D471/04 , C07C233/65 , C07C233/69 , C07C235/66 , C07C237/48 , C07C271/16 , C07C307/06 , C07C311/16 , C07C311/51 , C07C317/32 , C07D205/04 , C07D213/40 , C07D213/61 , C07D213/73 , C07D213/74 , C07D213/84 , C07D215/48 , C07D215/54 , C07D217/18 , C07D231/56 , C07D233/64 , C07D235/06 , C07D239/26 , C07D239/28 , C07D241/12 , C07D241/44 , C07D257/04 , C07D261/12 , C07D263/56 , C07D271/12 , C07D277/82 , C07D285/08 , C07D295/13 , C07D305/06 , C07D307/22 , C07D333/58 , C07D401/12 , C07D413/12
CPC classification number: C07D471/04 , C07C233/65 , C07C233/69 , C07C235/66 , C07C237/48 , C07C271/16 , C07C307/06 , C07C311/16 , C07C311/51 , C07C317/32 , C07D205/04 , C07D213/40 , C07D213/61 , C07D213/73 , C07D213/74 , C07D213/84 , C07D215/48 , C07D215/54 , C07D217/18 , C07D231/56 , C07D233/64 , C07D235/06 , C07D239/26 , C07D239/28 , C07D241/12 , C07D241/44 , C07D257/04 , C07D261/12 , C07D263/56 , C07D271/12 , C07D277/82 , C07D285/08 , C07D295/13 , C07D305/06 , C07D307/22 , C07D333/58 , C07D401/12 , C07D413/12
Abstract: Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
-
Patent Agency Ranking
公开(公告)号：US11384049B2
公开(公告)日：2022-07-12
申请号：US16849728
申请日：2020-04-15
Applicant: Vivace Therapeutics, Inc.
Inventor： Andrei W. Konradi , Tracy Tzu-Ling Tang Lin
IPC: C07C235/66 , C07C311/51 , C07D217/24 , C07D217/26 , C07D401/12 , C07D213/40 , C07C255/24 , C07D333/70 , C07D305/08 , C07D305/06 , C07D241/12 , C07D233/64 , C07D257/04 , C07D213/73 , C07D213/61
Abstract: Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating deseases, such as cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
-
公开(公告)号：US11192865B2
公开(公告)日：2021-12-07
申请号：US16640557
申请日：2018-08-20
Applicant: Vivace Therapeutics, Inc.
Inventor： Andrei W. Konradi , Tracy Tzu-Ling Tang Lin
IPC: C07D257/04 , A61P35/00 , C07D213/38 , C07D231/12 , C07D233/58 , C07D235/00 , C07D239/26 , C07D249/06 , C07D249/08 , C07D271/06 , C07D271/10 , C07D401/04 , C07D401/06
Abstract: Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
-
公开(公告)号：US11661403B2
公开(公告)日：2023-05-30
申请号：US17054756
申请日：2019-05-15
Applicant: Vivace Therapeutics, Inc.
Inventor： Andrei W. Konradi , Tracy Tzu-Ling Tang Lin
IPC: C07D271/113 , C07D413/04 , A61K47/06
CPC classification number: C07D271/113 , A61K47/06 , C07D413/04
Abstract: Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
-
公开(公告)号：US11420935B2
公开(公告)日：2022-08-23
申请号：US16849728
申请日：2020-04-15
Applicant: Vivace Therapeutics, Inc.
Inventor： Andrei W. Konradi , Tracy Tzu-Ling Tang Lin
IPC: C07C235/66 , C07C311/51 , C07D217/24 , C07D217/26 , C07D401/12 , C07D213/40 , C07C255/24 , C07D333/70 , C07D305/08 , C07D305/06 , C07D241/12 , C07D233/64 , C07D257/04 , C07D213/73 , C07D213/61
Abstract: Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating deseases, such as cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
-
公开(公告)号：US11186554B2
公开(公告)日：2021-11-30
申请号：US16609715
申请日：2018-05-02
Applicant: VIVACE THERAPEUTICS, INC.
Inventor： Andrei W. Konradi , Tracy Tzu-Ling Tang Lin
IPC: C07D257/04 , A61P35/00 , C07D231/12 , C07D249/08 , C07D401/04 , C07D401/06 , C07D403/04 , C07D403/06 , C07D405/04 , C07D413/06
Abstract: Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
-
-
-
-
-
-
-
Search Results
8
records
(took 0.032 seconds)
